RFL ▼ -5.8% - Rafael Holdings, Inc.
$RFL RFL-WT - Rafael Holdings Announces Submission of New Drug Application to FDA for Trappsol® Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C
29-OCT-2026 07:00 AM ET
Share this post
More filings for $RFL
RFL ▲ +6.9% - Rafael Holdings, Inc.Nov 3, 2026RFL ▼ -5.8% - Rafael Holdings, Inc.Oct 29, 2026RFL ▼ -44.9% - Rafael Holdings, Inc.Sep 30, 2026
View full $RFL filing history →💬 Comments
Loading comments…
Leave a comment
